Evidence map›Paper›PMID 41477064›Full record

ArticleArchives of rehabilitation research and clinical translation2025

A Dual Approach to Rehabilitation of an autoimmune ataxia : A case study involving the Adult-Onset Opsoclonus-Myoclonus-Ataxia Syndrome.

Joon Sin Ser, Kee Jin Loh, Sing Mei Chung, Mei Xian Tan, Evangeline Jia Yun How, San San Tay

Abstract readCase Reports
In one paragraph

Article in Archives of rehabilitation research and clinical translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joon Sin SerRehabilitation Medicine, Singhealth Residency, Singapore.
Kee Jin LohRehabilitation Medicine Department, Changi General Hospital, Singapore.
Sing Mei ChungRehabilitation Medicine Department, Changi General Hospital, Singapore.
Mei Xian TanRehabilitative Services, Changi General Hospital, Singapore.
Evangeline Jia Yun HowRehabilitative Services, Changi General Hospital, Singapore.
San San TayRehabilitation Medicine Department, Changi General Hospital, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) is a rare inflammatory neurologic condition predominantly described in pediatric populations. Adult-onset OMAS presents significant rehabilitation challenges because of limited literature and established treatment protocols. We report a middle-aged man with postinflammatory OMAS who underwent intensive inpatient rehabilitation using both conventional therapy and adjunct interventions, including robot-assisted gait training and hydrotherapy. The patient presented with characteristic opsoclonus, truncal ataxia, and bilateral dysmetria after an upper respiratory tract infection. After 22 days of intensive rehabilitation, the patient demonstrated remarkable functional improvement with a FIM efficiency of 1.77 and effectiveness of 0.84. Berg Balance Scale scores improved from 25 of 56 to 53 of 56, and the patient achieved modified independence in activities of daily living. While recovery occurred during rehabilitation, causality cannot be established, as improvement may also reflect the natural disease trajectory. Nevertheless, this case demonstrates the potential efficacy of combining conventional rehabilitation with targeted adjunct therapies for adult-onset OMAS, providing a rationale for a treatment strategy in rare neurologic conditions.

Indexed as

Case reportFunctional outcomeInflammatory ataxiaOMASRAGTRehabilitation

Identifiers

PMID41477064
PMCPMC12750422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.